Status:
COMPLETED
Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study
Lead Sponsor:
China Academy of Chinese Medical Sciences
Collaborating Sponsors:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Conditions:
Primary Hypertension
Hypertension, Resistant to Conventional Therapy
Eligibility:
All Genders
18-70 years
Phase:
EARLY_PHASE1
Brief Summary
The research of clinical effectiveness assessment is to explore the causal relationship between treatment and outcome.Accordingly, based on the effectiveness of tan-yu treatment, the research takes th...
Detailed Description
Background: Syndrome differentiation is one of the substantial characteristics in Traditional Chinese Medicine (TCM) but is still lack of scientific evidence.The inference methods of causal relationsh...
Eligibility Criteria
Inclusion
- Essential hypertension subjects, aged 18-70 years, blood pressure \> 140/90 mm Hg even used to be on 3 or more medications for a month and diagnosed as Phlegm and Stasis Syndrome will be included.
Exclusion
- Patients will be excluded for the following conditions: with secondary resistant hypertension because of other disease like renal disease or pheochromocytoma; included in other clinical trial in one month; pregnant or breast-feed or preparing for pregnancy female; combined with disease like stroke, coronary atherosclerotic heart disease, diabetes, chronic renal failure or mental disease.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT01904695
Start Date
August 1 2013
End Date
December 1 2015
Last Update
September 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China, 100700